Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
Clinical trial NCT03121586 · TERMINATED
Trial details
- NCT number
- NCT03121586
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2024-04-30
- Enrollment
- 995
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.